Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 32.48M | 24.32M | 2.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --32.48M | --24.32M | --2.11M | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 5,761.04%21.51M | 4,238.02%15.75M | 312.19%1.32M | 572.01%1.68M | 367K | 363K | 320K | 250.4K | 250.4K | 0 |
| Gross profit | 3,088.83%10.97M | 2,460.33%8.57M | 346.25%788K | -572.01%-1.68M | -367K | -363K | -320K | -250.4K | -250.4K | 0 |
| Operating expense | -84.57%3.94M | -74.51%4.55M | -63.49%5.39M | 219.70%103.63M | 123.07%25.54M | 749.31%17.83M | 621.99%14.77M | 14,126.45%32.41M | 19,137.33%16.82M | 22,072.77%11.45M |
| Selling and administrative expenses | -25.26%3.27M | -8.43%3.81M | 102.42%5.19M | 96.77%18.09M | 9.20%4.38M | 621.38%4.16M | 34.11%2.56M | 4,380.88%9.19M | 3,274.74%2.7M | 9,159.11%4.01M |
| -Selling and marketing expense | -9.06%974K | 17.73%976K | 329.62%1.58M | 94.32%5.26M | -43.11%1.07M | 515.49%829K | 1,365.61%368K | --2.71M | --666.1K | --1.88M |
| -General and administrative expense | -30.51%2.3M | -14.93%2.84M | 64.31%3.61M | 97.79%12.83M | 55.51%3.31M | 653.61%3.34M | 16.38%2.19M | 3,060.74%6.48M | 2,441.08%2.03M | 4,811.36%2.13M |
| Depreciation amortization depletion | ---- | ---- | --0 | ---- | ---- | ---- | --320K | ---- | ---- | ---- |
| -Depreciation and amortization | ---- | ---- | --0 | ---- | ---- | ---- | --320K | ---- | ---- | ---- |
| Other operating expenses | -96.84%669K | -94.64%733K | -98.30%207K | 268.36%85.54M | 184.42%21.17M | 797.81%13.67M | 8,915.25%12.21M | 102,268.84%23.22M | 187,520.61%14.12M | 89,092.84%7.44M |
| Operating profit | 127.12%7.03M | 122.10%4.02M | 69.48%-4.61M | -222.40%-105.31M | -126.28%-25.91M | -766.59%-18.2M | -637.64%-15.09M | -14,236.35%-32.66M | -19,423.74%-17.07M | -22,072.77%-11.45M |
| Net non-operating interest income (expenses) | -35.83%-887K | 75.26%-681K | -586.67%-412K | -1,098.35%-4.69M | -326.99%-653K | -6,831.55%-2.75M | -361.29%-60K | 1,220.66%469.32K | 616.65%117.79K | 2,465.07%287.67K |
| Non-operating interest income | -73.55%128K | -51.01%169K | 32.58%175K | 175.37%1.31M | 68.25%484K | 743.58%345K | 474.84%132K | 1,237.90%475.45K | 653.94%123.92K | 2,465.07%287.67K |
| Non-operating interest expense | -10.73%1.02M | -6.49%850K | 205.73%587K | 97,725.49%5.99M | --1.14M | --909K | --192K | --6.13K | --6.13K | --0 |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | --2.19M | ---- | ---- | ---- | ---- |
| Other net income (expenses) | -906.61%-8.53M | 133.77%694K | -51,263.64%-5.65M | -1,762.09%-5.79M | -285.56%-847K | -2.06M | -11K | -311.16K | -91.48K | -219.68K |
| Gain on sale of security | -593.02%-1.7M | 1,760.45%3.65M | -709.09%-89K | -574.19%-2.1M | 256.59%344K | ---220K | ---11K | ---311.16K | ---91.48K | ---219.68K |
| Special income (charges) | --0 | --0 | ---- | ---126.46K | --1.09M | ---126K | ---- | --0 | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | --126.46K | ---- | --126K | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | --0 | ---- | ---- | ---- | --1.09M | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -199.30%-6.83M | -73.14%-2.96M | ---5.56M | ---3.57M | ---2.28M | ---1.71M | ---- | ---- | ---- | ---- |
| Income before tax | 91.30%-2.39M | 117.54%4.04M | 29.64%-10.67M | -256.20%-115.79M | -140.81%-27.41M | -1,017.35%-23M | -649.52%-15.16M | -16,803.34%-32.51M | -23,906.86%-17.04M | -28,055.60%-11.38M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 91.30%-2.39M | 117.54%4.04M | 29.64%-10.67M | -256.20%-115.79M | -140.81%-27.41M | -1,017.35%-23M | -649.52%-15.16M | -16,803.34%-32.51M | -23,906.86%-17.04M | -28,055.60%-11.38M |
| Net income continuous operations | 91.30%-2.39M | 117.54%4.04M | 29.64%-10.67M | -256.20%-115.79M | -140.81%-27.41M | -1,017.35%-23M | -649.52%-15.16M | -16,803.34%-32.51M | -23,906.86%-17.04M | -28,055.60%-11.38M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 91.30%-2.39M | 117.54%4.04M | 29.64%-10.67M | -256.20%-115.79M | -140.81%-27.41M | -1,017.35%-23M | -649.52%-15.16M | -16,803.34%-32.51M | -23,906.86%-17.04M | -28,055.60%-11.38M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 91.30%-2.39M | 117.54%4.04M | 29.64%-10.67M | -256.20%-115.79M | -140.81%-27.41M | -1,017.35%-23M | -649.52%-15.16M | -16,803.34%-32.51M | -23,906.86%-17.04M | -28,055.60%-11.38M |
| Diluted earnings per share | 90.00%-0.01 | 110.00%0.01 | 57.14%-0.03 | -50.00%-0.45 | -42.86%-0.1 | -150.00%-0.1 | -40.00%-0.07 | -2,900.00%-0.3 | -0.0792 | -2,474.48%-0.07 |
| Basic earnings per share | 90.00%-0.01 | 110.00%0.01 | 57.14%-0.03 | -50.00%-0.45 | -42.86%-0.1 | -150.00%-0.1 | -40.00%-0.07 | -2,900.00%-0.3 | -0.0792 | -2,474.48%-0.07 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.